Justin Balko
Vanderbilt-Ingram Cancer Center (VICC)
Program in Cancer Biology
Department of Medicine
Division of Hematology and Oncology
Vanderbilt Institute for Infection, Immunology and Inflammation (VI4)
VICC Host-Tumor Interactions Research Program
Our laboratory is focused on improving treatment oucomes in breast cancer (particularly triple-negative breast cancer) as well as in other solid tumors. To accomplish this, we integrate data from genomic and molecular profiling studies with molecular biology and signal transduction methodologies to translationally identify altered pathways in cancer, the functional consequences of these alterations, and ways to directly target them in patients to improve clinical outcomes and survival.
Our laboratory is focused on improving treatment oucomes in breast cancer (particularly triple-negative breast cancer) as well as in other solid tumors. To accomplish this, we integrate data from genomic and molecular profiling studies with molecular biology and signal transduction methodologies to translationally identify altered pathways in cancer, the functional consequences of these alterations, and ways to directly target them in patients to improve clinical outcomes and survival.
Keywords: immunotherapy , breast cancer , melanoma , translational , computational biology
Research Area: Computational and Systems Biology , Genomics , Cancer Biology , Cell Signaling , Cancer Immunology